menactra Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials
Online Trials

Any (4)

Phase 3 (4)

Interventional (4)

Sanofi Pasteur, a Sanofi Company (4)

Yes (4)

Updated trials (3)

No (4)

I am/have/had

added new label for I am/have/had

I am looking for

I am looking forAccepts healthy volunteers

added new label for I am looking for

Advanced Filters

Found 4 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 3
Recruiting in 1000s
Interventional Study
For all genders
Recruiting

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, and Children in India and Healthy Adolescents and Children in the Republic of South Africa (MET55)

The primary objective of this study is to demonstrate the non-inferiority of immunogenicity of a single dose of MenACYW conjugate vaccine compared to Menactra® in adolescents and children aged 2

Accepts healthy volunteers

0 views
13 May, 2022
12 locations

Multi-country trial
Phase 3
For pediatric ages
For adults
Recruiting in 1000s
Interventional Study
For all genders
Recruiting

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Menactra®.

Accepts healthy volunteers

0 views
13 May, 2022
50 locations

Multi-country trial
Phase 3
Recruiting in 1000s
Interventional Study
For all genders
Recruiting

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, and Children in India and Healthy Adolescents and Children in the Republic of South Africa (MET55)

The primary objective of this study is to demonstrate the non-inferiority of immunogenicity of a single dose of MenACYW conjugate vaccine compared to Menactra® in adolescents and children aged 2

Accepts healthy volunteers

310 views
19 Mar, 2022
12 locations

Multi-country trial
Phase 3
For pediatric ages
For adults
Recruiting in 1000s
Interventional Study
For all genders
Recruiting

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Menactra®.

Accepts healthy volunteers

560 views
26 May, 2022
50 locations